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Resumo
A esplenose intra-hepática é um autotransplante 
heterotópico de tecido esplénico no fígado.
Os autores apresentam o caso de um homem 
de 48 anos com doença hepática crónica que 
apresentou dois nódulos hepáticos em exames 
de rotina. As características dos nódulos em 
RM levaram os autores a levantar a hipótese 
de esplenose intra-hepática (EIH) mas um 
hepatocarcinoma não podia ser excluído. Os 
resultados da cíntigrafia com Tc-99m-DRBC não 
favoreceram a hipótese de EIH e o paciente foi 
submetido a cirurgia para resseção dos nódulos. 
A histologia confirmou o diagnóstico de EIH.
Este caso demonstra a importância de considerar 
a EIH no diagnóstico diferencial de nódulos 
hepáticos.
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Abstract
Intrahepatic splenosis is the heterotopic 
autotransplantation of  splenic tissue in the liver.
We present a case of  a 48-year-old male with 
chronic hepatic disease with two hepatic nodules 
on routine imaging. The nodule’s characteristics 
on MRI made us raise the hypothesis of  
intrahepatic splenosis (IHS) but hepatocellular 
carcinoma could not be ruled out. Tc-99m-
DRBC scintigraphy results did not favour the IHS 
hypothesis and the patient underwent surgery 
to resect the nodules. Histology confirmed the 
diagnosis of  IHS.
This report demonstrates that IHS should be 
considered in the differential diagnosis of  hepatic 
nodules. 
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Radiological Case Report / Caso Clínico
Background
Splenosis is defined as the heterotopic autotransplantation 
of  splenic tissue throughout the peritoneal cavity, which 
frequently seeds onto exposed vascularized peritoneal surfaces 
in up to 67% of  patients following splenic trauma or surgery.1,2 
Most of  the reported cases of  splenosis occurred as a result 
of  trauma or iatrogenesis involving the spleen early in life. The 
average interval between the initial trauma or surgery and the 
onset of  splenosis ranges from 5 months to 32 years and lasts 
an average of  10 years.3
Because there are various sites of  splenosis and it can occur in 
variable shapes and sizes, it is often misdiagnosed by clinicians. 
Particularly, it can be misdiagnosed as a malignant tumor.4
There are few reports in the literature regarding intrahepatic 
splenosis (IHS), which can be mistaken for a hepatic tumor.5 -7
The frequency of  IHT is likely underestimated because most 
splenic implants are asymptomatic and only found either 
incidentally or after symptomatic complications.
Surgical intervention has been reported to be unnecessarily 
performed to arrive at the correct diagnosis.7
Case Presentation
A 48-year-old male was followed in our hospital internal 
medicine consultation because of  chronic heart failure and 
chronic hepatic disease of  alcoholic origin.  
He had a medical history of  hypertension and type 2 
diabetes, dilated miocardiopathy associated with the 
alcohol consumption and had undergone splenectomy for 
traumatic splenic rupture 30 years ago. His family history 
was non-specific.
The physical examination showed that the patient was in 
good overall health, anicteric, with no pain in the abdomen, 
and had no palpable masses.
Blood examination revealed normal levels of  hepatic 
enzymes and of  the alpha-fetoprotein. 
An abdominal ultrasound was requested to evaluate the 
chronic hepatitis and showed two solid and hipoecoic liver 
nodules (Figure 1). 
Abdominal contrasted CT revealed lobulated hepatic 
contour suggesting chronic hepatic disease and two well-
circumscribed, low density nodules, measuring 20 mm in 
the subcapsular region of  the segment 7 and 25 mm in the 
segment 2. The dynamic study showed that both lesions 
had homogeneous enhancement in the arterial phase and 
“fading” during portal and equilibrium phases (Figures 2 
and 3). 
Further characterization was made by magnetic resonance 
imaging (MRI) (Figures 4 - 5), and both lesions had 
homogeneous arterial enhancement and washout in the 
subsequent phases of  the dynamic contrasted study. 
However, although they were difficult to depict on T2-
weighted images, there was slight hypointensity. The nodule 
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Fig. 1 – Abdominal ultrasound shows 
two solid, hypoecoic liver nodules: 
nodule one (a) - measuring about 3 cm 
in the subcapsular region of  segment 
2; nodule two (b) -  measuring 2 cm in 
segment 7.
Fig. 2 – Contrast enhanced abdominal CT depicting the nodule (arrow) in 
segment 2 – a) on the unenhanced image the nodule is hard to identify; b) 
arterial phase shows clear homogenous enhancement of  the nodule that 
fades on portal (c) and late (d) phases.
Fig. 3 – Contrast enhanced abdominal CT depicting the nodule in segment 
7 – the nodule (arrow) has similar behavior to the nodule in figure 2.
Fig. 4 – MRI of  the abdomen – out (a) 
and in (b) phases show the hypointense 
nodule (arrow) in the segment 2. There 
is no loss of  signal in the out-of-phase 
image to suggest fat content. 
Unenhanced T1-weighted image (c) 
shows the hipointense nodule (arrow). 
There is homogeneous enhancement 
of  the nodule in the arterial phase 
(d) and washout during portal (e) and 
subsequent phases (f  and g). These 
characteristics are concerning for 
hepatocellular carcinoma (HCC). 
On T2-weighted image without fat 
saturation (h) the nodule is isointense 
to the remaining hepatic parenchyma, 
which is not the most typical behavior 
of  HCC. 
Note that the spleen is absent and 
that there is an image in the splenic 
bed (dashed arrow) with similar 
characteristics to the hepatic nodule 
described.
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on segment 7 showed a halo of  fat in the out-of-phase 
images but no fat was seen inside the lesion. Based on 
these characteristics, hepatocellular carcinoma could not be 
ruled out but there was an image on the post-splenectomy 
bed that had similar behavior so we raised the hypothesis 
of  these hepatic nodules being nodules of  intra-hepatic 
splenosis.
Tc-99m-labelled heat-denaturated autologous red blood 
cells scintigraphy (Tc-99m-DRBC scintigraphy) was 
performed and planar images, single photon emission 
computed tomography (SPECT) and a low-dose CT were 
acquired for attenuation correction and anatomical location, 
2 hours after administration of  the radiopharmaceutical. 
A mild uptake in the post-splenectomy bed was observed, 
suggestive of  a splenosis implant (Figure 6). 
The liver uptake was globally homogenous with no focal 
uptake in the region of  the previously mentioned lesions 
(Figure 7). These findings did not favor the hypothesis of  
IHS. 
Given the findings described, the patient underwent surgery 
for resection of  the hepatic nodules. 
Histopathologic examination showed well-demarcated 
nodules of  splenic tissue, in the visceral peritoneal surface 
of  the liver (Figure 8a), which were surrounded by a 
fibrous capsule and composed by sinusoidal structures with 
congestion and lymphoid sheaths with scattered follicular 
aggregates, denoting red and white pulp, respectively 
(Figure 8b). No hilus was identified. No evidence of  
malignancy was found. Thus, these features allowed the 
final diagnosis of  splenosis.
Fig. 5 – MRI of  the abdomen – out (a) 
and in (b) phases show the hypointense 
nodule (arrow) in the segment 2. 
There is a halo of  signal loss in the 
out-of-phase image surrounding the 
nodule (dashed arrow), suggesting the 
existence of  a capsule with fat. There 
is no signal loss inside the nodule. 
Unenhanced T1-weighted image (c) 
shows the hipointense nodule (arrow). 
There is homogeneous enhancement 
of  the nodule in the arterial phase 
(d) and washout during portal (e) and 
subsequent phases (f  and g). These 
characteristics are similar to the nodule 
described in segment 2. On T2-weighted 
image without fat saturation (h) the 
nodule is isointense to the remaining 
hepatic parenchyma (arrow) and the 
hyperintense capsule (dashed arrow) is 
noted, suggesting fat content. 
Fig. 6 – SPECT-CT fusion images of  
the abdominal region- mild uptake in the 
post-splenectomy bed at the Scintigraphy 
suggesting splenosis focus. Liver uptake 
was globally homogenous with no focal 
uptake at the site of  the lesions depicted 
on MRI.
Discussion
Splenosis is recognized as a heterotopic autotransplantation 
of  splenic tissue following splenic trauma or surgery.  The 
disrupted splenic fragments seed the peritoneal surface, 
acquire a vascular supply, and become clinically evident 
as a result of  regrowth at the implantation sites. Splenosis 
implants are usually multiple, supplied by arteries from 
the surrounding tissue and typically have neither hilus nor 
normal elastic muscular capsule.7,8 The case herein reported 
is characterized by similar features, demonstrating splenosis 
implants on the liver surface, surrounded only by a fibrous 
capsule.
Most commonly, these implants are not of  clinical 
significance and are often incidentally detected at autopsy 
or during abdominal surgery.9
Although splenosis can occur anywhere, the implants are 
found most commonly in the peritoneal cavity, such as 
mesentery, omentum and other peritoneal surfaces.10
Splenosis is a distinct entity from accessory spleens, which 
represent failure of  the splenic anlagen to fuse during 
embryogenesis and can be found in 10–40% of  patients 
at autopsy and rarely exceed 1.5 cm in diameter. Accessory 
Fig. 7 – SPECT-CT fusion images of  
the abdominal region- liver uptake was 
globally homogenous with no focal 
uptake at the site of  the lesions depicted 
on MRI.
Fig. 8 – Histological features of  splenosis. (A) Photomicrography showing 
the splenic tissue surrounded by a fibrous capsule in the visceral peritoneal 
surface of  the liver (H&E, x40); (B) Higher magnification view of  splenic 
tissue showing red pulp composed of  vascular sinuses with congestion 
and white pulp composed of  lymphoid aggregates (H&E, x100).
spleens are usually solitary, rarely exceed six in number, and 
are most commonly located on the left side of  the dorsal 
mesogastrium in the region of  the splenopancreatic or 
gastrosplenic ligaments. Histologically, accessory spleens 
resemble the normal spleen which contain a hilus, a 
capsule, parenchyma with normal pulp and always receive 
blood supply from branches of  the splenic artery.11
Intrahepatic splenosis is the heterotopic autotransplantation 
of  splenic tissue in the liver. The pathogenesis of  intrahepatic 
splenosis is still unclear. However, it is considered to 
develop from seeding of  splenic fragments into serosal 
surfaces at the time of  splenic trauma or splenectomy. 
Moreover, based on the susceptibility of  the splenic 
erythropoiesis response to hypoxia and the inevitability of  
hypoxia caused by aging or pathological changes, the two 
events, 1) the migration of  the erythrocytic progenitor cells 
via the portal vein following traumatic splenic rupture and 
2) the induction of  erythropoiesis by local hypoxia of  liver, 
might cause the occurrence of  the intrahepatic splenosis.8,12
Fewer than 20 cases of  intrahepatic splenosis have been 
reported until now. However, IHS is not widely recognized 
by most physicians; therefore, its incidence may be 
underestimated.11
IHS can be misdiagnosed as liver cancer and have 
patients undergo surgical resection, in which case it is 
only intraoperatively that the splenic tissue is found and 
confirmed by subsequent surgical pathology. 
AFP is the most commonly used indicator of  HCC 
screening and it plays an important role in the diagnosis, 
the evaluation of  clinical efficacy, and the monitoring of  
tumor relapse. However, the AFP level may be normal in 
35% to 45% of  HCC patients, indicating the diagnostic 
limits of  single HCC biomarker and nearly 40% of  HCC 
patients may be missed.13
There are no typical radiological features of  intrahepatic 
splenosis and it is usually difficult to distinguish this 
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